NCT00645554View on ClinicalTrials.gov

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 2004

Conditions
Pharmacokinetics
Interventions
DRUG

Galantamine oral solution

All Listed Sponsors
lead

Xian-Janssen Pharmaceutical Ltd.

INDUSTRY

NCT00645554 - A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers | Biotech Hunter | Biotech Hunter